U.S. Medical Equipment Stock News

Phathom Pharmaceuticals came into this earnings print with a bruised stock chart, down double digits over the past month and quarter, and it slipped another 3.1% to US$8.75 in the first full trading day after results. The headline, however, is not the share price. The company reported its first quarter of operating profit on a cash basis excluding stock based compensation, on revenue of US$74.3m. For a gastrointestinal focused biotech that has been firmly in loss making territory, that shift...

Netlist stock barely flinched after earnings, slipping just 1.3% to US$2.35, yet the report itself was anything but quiet. For a memory and DRAM resale specialist that has swung between losses and thin profits, Q2 landed with a clear headline. Revenue reached US$109.8m and net income stayed positive, although earnings per share softened sharply from Q1. The market reaction so far looks more like a shrug than a verdict. With profit now fragile again after a strong first quarter, the key...

Baxter International stock cooled off today, slipping about 2% after a strong multi month run, even as the earnings story pointed in the opposite direction. The headline was a clean beat on Q2, with revenue around US$3.0b and adjusted earnings per share of US$0.56. Management also raised full year adjusted earnings guidance to a range of US$1.95 to US$2.15. For a company still working through a turnaround and balance sheet repair, that is a meaningful reset of expectations. The market...

GBank Financial Holdings stock slipped about 1.5% to US$20.70, capping a weak stretch that has left shares under pressure in recent months. The immediate reaction focuses on that red screen and on modest top line revenue of US$19.1m for the quarter. The more important story sits in the earnings power behind it. Basic earnings per share jumped to roughly US$0.38 and net income reached about US$5.5m, which is notable for a bank already flagged for both strong growth forecasts and meaningful...

Federal Agricultural Mortgage stock climbed 3.3% to about US$227.60 into the close, which indicates investors responded positively to the results. The question is whether that move properly reflects the earnings impact of record quarterly revenue of US$125m and core earnings of US$59m, or if the market is only reacting to the headline beats. The key factor in this report is profitability. A quarterly return on equity of 18.9% is notable for a specialized agricultural lender and it puts the...

BigBear.ai slipped 1.4% to US$2.79 into the close, which looks surprisingly calm for a stock tied to one of the hotter themes in the market, applied artificial intelligence. The real story in this quarter is not the small price move. It is a revenue line holding at US$36.7m and a loss that remains heavy at US$25.7m, even after a prior year distorted by large non cash items. The gap between a relatively steady share price and a still loss making income statement is the sentiment fault line...

Markets are wrestling with mixed growth signals, sticky inflation in parts of Europe, shifting central bank paths, and uneven demand across Asia and emerging markets. In this kind of cross current, cash generation and valuation discipline matter. The Undervalued Stocks Based On Cash Flows screener focuses on companies where current prices sit below an internally assessed fair value using SWS DCF work, while cash flow profiles still look promising. For investors who want valuation support...

The market raced ahead of the story on Patterson-UTI Energy. The stock jumped 6.4% to US$10.48 into the earnings print after a strong month that already had traders leaning bullish. The headline from the quarter is simple. This is still a loss making oilfield services company that just put up roughly US$1.23b in revenue and a net loss of about US$20m. Today’s pop looks driven less by that loss and more by investors grabbing onto the improving rig and frac activity narrative that sat between...

Blue Owl Capital stock inched up about 1.4% to US$10.30 after earnings, a relatively calm move for a company that just put a very rich 86x P/E and an almost 9% dividend yield back under the microscope. The headline this quarter is margin pressure. Quarterly basic EPS landed at a little under US$0.02 and trailing net profit margin sits at 2.7%, with results still carrying the weight of a US$262.4m one off loss. Short term traders may focus on the modest price gain. Long term holders will be...

Spok Holdings stock barely flinched after earnings, ticking up about 1.4% as if investors were still on the fence. That muted move sits against a quarter where healthcare communication software did the heavy lifting, with Q2 revenue of about US$35.0 million and net income of roughly US$4.1 million. The headline is not explosive growth. It is a cleaner profit story, record adjusted EBITDA, and a dividend yield above 10% that still raises hard questions about how long this payout can run at...

The market barely blinked at Climb Global Solutions today. The stock inched up only 0.3% to US$26.81, even after a fresh quarter that showed solid software distribution traction but thinner profitability. That muted move hides the real story. Climb Global Solutions delivered US$174.2m in Q2 net sales and US$0.30 in basic earnings per share while adjusted EBITDA margin on gross profit compressed. For short term traders the flat reaction may look uneventful. For investors thinking in years, the...

Illumina walked into this earnings print with the stock essentially flat on the day, trading near US$205 after a strong 90 day run. The market did not stampede in either direction; however, the quarter itself was anything but quiet. Revenue landed at about US$1.16b and non GAAP earnings per share reached roughly US$1.31, both tied closely to clinical sequencing strength and NovaSeq X adoption. For a company often viewed as a long term genomics platform story, the real headline this time is...

Laureate Education stock barely flinched after earnings, slipping just 0.3% to US$38.31 even as the company posted another heavy hitting quarter. Revenue reached US$615.9m and basic earnings per share landed at US$0.98, both tied to strong enrollment and profit execution in its Latin American university network. The real story for you is not today’s small price move. It is the multi quarter pattern of higher margins, raised full year guidance and a P/E that still sits modestly below sector...

PennyMac Mortgage Investment Trust stock inched up 1.3% to US$9.43, a modest bounce that sits awkwardly against a far tougher 30 day stretch and weaker 90 day run. The market gave a cautious nod, not a standing ovation. What really moved the needle was not headline earnings per share but the pressure between the current US$0.40 dividend and a run rate that management pegs at about US$0.33 per quarter. The small price gain suggests investors are treating this as a relief day, while the...

Medallion Financial slipped about 2% to US$9.94 today, even though the latest quarter showed the lending engine still running hard. Revenue reached roughly US$88.9m and net income came in at about US$7.4m. However, the stock reaction reflects concern about what those profits cost to produce. The central issue is the margin squeeze now building across the Medallion Financial model. Net income over the past year has been running on thinner margins, and interest expense coverage remains weak...

Old National Bancorp stock barely flinched after earnings, up only 0.9% to US$26.64, even as the bank delivered one of its cleanest quarters in recent memory. The market is treating this like a routine update. The numbers tell a different story. The real headline is profit quality. Basic earnings per share reached about US$0.65 and net income excluding extra items came in near US$249.4m, both supported by firm credit, rising loans and a cost to income ratio just above 47%. For a regional...

KKR stock barely flinched after earnings, closing up just 0.45% around US$101 even as the company reported what it called a record quarter. The market reaction was muted, but the headline story is clear. Fee related earnings per share hit US$1.32 with a fee margin of roughly 70%, and adjusted net income per share reached US$1.63. That kind of profitability profile matters far more than a one day move. For anyone thinking in years rather than days, the key question now is how durable that...

Quaker Chemical stock jumped 3.6% to US$160.52 into the close, and the move lines up with the story in the earnings. The market is latching onto one thing above all else: this quarter was about profit power. Adjusted EBITDA hit a record US$85m with margin at 16%, and non GAAP earnings per share came in at US$2.19. For a specialty chemicals supplier that lives or dies on mix and efficiency, that margin performance is what is driving today’s relief in the share price. Is Quaker Chemical now a...

Columbia Sportswear walked into this earnings season with a stock that had already cooled, down over the past month and quarter, and the Q2 print just shaved off more confidence. The share price dropped 5.4% today to US$59.38 as investors reacted to results that relied heavily on a one time US$78 million tariff refund to lift reported profit. Behind that accounting boost, net sales landed at US$614 million and earnings per share came in at roughly US$0.52. The market is now asking how much of...

Applied Digital entered this earnings day with a bruised stock, down about 23% over the past month, and the initial reaction stayed cautious as the shares slipped another 2.1% to close near US$27.40. That move underlines a simple message: the market is still wrestling with a high growth, high valuation story funded by heavy debt. The headline this quarter is not the revenue line. It is the strain from building a US$4.2b cash and US$5.0b debt balance sheet around long term hyperscale data...

LPL Financial Holdings stock has delivered a strong 150.1% return over the past 5 years, yet the valuation picture is mixed as the Excess Returns intrinsic value estimate points to upside while market based multiples suggest the shares are on the expensive side. A 150.1% gain over 5 years highlights that long term shareholders in LPL Financial Holdings have already captured substantial value, which raises the bar for future returns to justify the current share price. Investment in the new...

Darling Ingredients stock barely flinched after earnings, slipping about 1% to around US$60, even as the quarter delivered one of the sharpest profit rebounds in the sector. Net income for Q2 2026 landed at US$387.3m on revenue of US$1.7b, turning what was a grinding recovery story into a very different earnings picture. Short term traders may see a flat chart. Longer term investors will focus on what this kind of profitability means for Darling Ingredients as it leans on higher margin...

The market barely flinched at Amneal Pharmaceuticals, with the stock easing about 1% to US$18.32 even after a once again stronger profit story. Q2 headline numbers were clean and pharma focused. Revenue reached US$796 million and adjusted earnings per share landed at US$0.30. Adjusted EBITDA came in at US$206 million. All three sat comfortably within a raised full year outlook. For a stock that has climbed more than 40% over the past three months, that muted move hints at investors wrestling...

Civeo slipped about 1.6% today, a mild pullback for a stock that has already eased over the past month. The mood looks more cautious than panicked, which fits a quarter that kept the recovery story intact but still in the loss column. The headline is simple: Revenue reached about US$180m and adjusted earnings before interest, tax, depreciation and amortization came in near US$23.8m, yet Civeo again reported a net loss of roughly US$2.5m. For investors, the real question now is whether this...